TRIPODI, FARIDA
 Distribuzione geografica
Continente #
NA - Nord America 4.541
EU - Europa 3.310
AS - Asia 1.377
SA - Sud America 203
AF - Africa 29
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.472
Nazione #
US - Stati Uniti d'America 4.429
IT - Italia 1.128
DE - Germania 528
SG - Singapore 478
RU - Federazione Russa 446
CN - Cina 385
SE - Svezia 291
IE - Irlanda 195
BR - Brasile 194
HK - Hong Kong 141
UA - Ucraina 131
GB - Regno Unito 111
CA - Canada 96
VN - Vietnam 89
FR - Francia 87
PL - Polonia 85
IN - India 72
TR - Turchia 72
FI - Finlandia 68
ID - Indonesia 62
AT - Austria 50
DK - Danimarca 38
NL - Olanda 34
BE - Belgio 32
ES - Italia 32
KR - Corea 17
CH - Svizzera 14
MX - Messico 14
CZ - Repubblica Ceca 12
RO - Romania 11
IR - Iran 9
PK - Pakistan 8
EG - Egitto 7
CY - Cipro 6
NZ - Nuova Zelanda 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
MU - Mauritius 5
PH - Filippine 5
TH - Thailandia 5
BD - Bangladesh 4
BG - Bulgaria 4
PT - Portogallo 4
TW - Taiwan 4
ZA - Sudafrica 4
CL - Cile 3
EU - Europa 3
JP - Giappone 3
MA - Marocco 3
UZ - Uzbekistan 3
AU - Australia 2
HR - Croazia 2
IL - Israele 2
LB - Libano 2
LV - Lettonia 2
MY - Malesia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CO - Colombia 1
EC - Ecuador 1
ET - Etiopia 1
GR - Grecia 1
IQ - Iraq 1
KE - Kenya 1
KZ - Kazakistan 1
LT - Lituania 1
MQ - Martinica 1
NG - Nigeria 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
VE - Venezuela 1
Totale 9.472
Città #
Ann Arbor 1.096
Milan 445
Singapore 344
Woodbridge 313
Fairfield 301
Wilmington 272
Chandler 269
Frankfurt am Main 265
Ashburn 249
Houston 227
Dublin 188
Seattle 138
Hong Kong 137
Jacksonville 123
New York 109
Dearborn 106
Santa Clara 106
Cambridge 95
Kraków 81
Princeton 66
Nanjing 64
Dong Ket 63
Shanghai 57
Jakarta 53
Munich 41
Helsinki 40
Moscow 40
Oakland 37
Vienna 37
Altamura 36
Brussels 32
Lawrence 31
Toronto 29
Hyderabad 28
Beijing 26
Hefei 24
Los Angeles 24
Council Bluffs 23
Guangzhou 23
Lachine 23
Fremont 22
Nanchang 18
Ottawa 18
Boardman 17
San Diego 17
Bari 15
Tianjin 15
Andover 14
Como 14
Nuremberg 14
Shenyang 14
Bonndorf 13
Desio 13
Hangzhou 13
Monza 13
Washington 13
Granada 12
Mexico City 12
Zhengzhou 12
Jinan 11
London 11
Montréal 11
Norwalk 11
Pioltello 11
Rome 11
Brescia 9
Falls Church 9
Heidelberg 9
Jiaxing 9
Kocaeli 9
Kochi 9
Modena 9
Mountain View 9
Parma 9
São Paulo 9
Dallas 8
Hebei 8
Kunming 8
Melegnano 8
Senago 8
Edmonton 7
Genoa 7
Huizen 7
Kassel 7
Mannheim 7
Montpellier 7
Vercelli 7
Verona 7
Zurich 7
Bonate Sopra 6
Chicago 6
Melzo 6
Napoli 6
Nicosia 6
North Bergen 6
Qingdao 6
Recife 6
Romola 6
Stockton 6
Amsterdam 5
Totale 6.264
Nome #
Post-translational modifications on yeast carbon metabolism: Regulatory mechanisms beyond transcriptional control 599
1,4-Diaril-2-Azetidinoni ad attività antitumorale. 359
Respiratory metabolism and calorie restriction relieve persistent endoplasmic reticulum stress induced by calcium shortage in yeast 358
Targeting GRP receptor: design, synthesis and preliminary biological characterization of new non-peptide antagonists of bombesin 326
Protective effect of Vigna unguiculata extract against aging and neurodegeneration 315
Snf1/AMPK is involved in the mitotic spindle alignment in Saccharomyces cerevisiae 313
The regulatory role of key metabolites in the control of cell signaling 310
Methionine supplementation stimulates mitochondrial respiration 277
On-cell Saturation Transfer Difference NMR study of Bombesin binding to GRP receptor 269
Methionine Supplementation Affects Metabolism and Reduces Tumor Aggressiveness in Liver Cancer Cells 265
Enhanced amino acid utilization sustains growth of cells lacking Snf1/AMPK 257
NMR analysis of budding yeast metabolomics: A rapid method for sample preparation 247
Nutritional modulation of CK2 in Saccharomyces cerevisiae: regulating the activity of a constitutive enzyme 246
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer 246
Cell growth and cell cycle In Saccharomyces cerevisiae: basic regulatory design and protein-protein interaction network 242
An acidic loop and cognate phosphorylation sites define a molecular switch that modulates ubiquitin charging activity in cdc34-like enzymes 241
Dual action antifungal small molecule modulates multidrug efflux and TOR signaling 237
CK2 activity is modulated by growth rate in Saccharomyces cerevisiae 236
Conventional and emerging roles of the energy sensor snf1/AMPK in saccharomyces cerevisiae 232
Synthesis and biological evaluation of new 3-amino-2-azetidinone derivatives as anti-colorectal cancer agents 226
Synthesis and biological evaluation of 1,4-diaryl-2-azetidinones as specific anticancer agents: activation of adenosine monophosphate-activated protein kinase and induction of apoptosis 218
AMPK Phosphorylation Is Controlled by Glucose Transport Rate in a PKA-Independent Manner 217
Snf1 phosphorylates adenylate cyclase and negatively regulates protein kinase A-dependent transcription in Saccharomyces cerevisiae 216
Snf1/AMPK promotes SBF and MBF-dependent transcription in budding yeast 215
The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin 197
Synthesis and biological evaluation of combretastatin analogs as cell cycle inhibitors of the G1 to S transition in Saccharomyces cerevisiae 195
Protein Kinase CK2 Holoenzyme Promotes Start-Specific Transcription in Saccharomyces cerevisiae 189
2013.Use of 1,4-diaryl-2-azetidinone compound as antitumor agent for treating lung cancer, large-cell lung cancer, renal carcinoma, prostate cancer, testicular cancer, ovarian cancer, bladder cancer and melanoma Patent Number(s): WO2013017548-A1 189
Protein Kinase CK2: a major regulator of the G1/S transition in Saccharomyces cerevisiae 176
In CK2 inactivated cells the cyclin dependent kinase inhibitor Sic1 is involved in cell-cycle arrest bifore the onset of S phase 175
Advanced techniques and nanotechnologies for point-of-care testing 172
A surface-activated chemical ionization approach allows quantitative phosphorylation analysis of the cyclin-dependent kinase inhibitor Sic1 phosphorylated on Ser201 152
Anti-aging effects of plant extracts on eukaryotic models of Parkinson’s disease 149
The CK2 phosphorylation of catalytic domain of Cdc34 modulates its activity at the G1 to S transition in Saccharomyces cerevisiae 148
Advancements in nanosensors for detecting pathogens in healthcare environments 141
Anti-Aging and Neuroprotective Properties of Grifola frondosa and Hericium erinaceus Extracts 131
Insulin and serine metabolism as sex-specific hallmarks of Alzheimer's disease in the human hippocampus 123
Snf1/AMPK fine-tunes TORC1 signaling in response to glucose starvation 115
The number of SCB elements in the promoters of G1-regulon genes affects their expression during the G1/S phase transition 115
Serine metabolism during differentiation of human iPSC-derived astrocytes 104
Anti-aging effects of plant extracts on eukaryotic models of Parkinson’s disease 97
Recent developments in the production and utilization of photosynthetic microorganisms for food applications 86
Exploiting Natural Niches with Neuroprotective Properties: A Comprehensive Review 83
Neuroprotective effects of plant extracts on eukaryotic models of Parkinson’s disease 79
Targeting protein aggregation using a cocoa-bean shell extract to reduce α-synuclein toxicity in models of Parkinson's disease 69
Exploring carbon source related localization and phosphorylation in the Snf1/Mig1 network using population and single cell-based approaches 50
Characterization of Cacoa extract in eukaryotic models of Parkinson’s disease 47
Neuroprotective effects of plant extracts on eukaryotic models of Parkinson’s disease 46
Neuroprotective effects of plant extracts on eukaryotic models of Parkinson’s disease 44
Characterization of plant bioactive molecules in eukaryotic models of Parkinson’s disease 39
Characterization of plant bioactive molecules in eukaryotic models of Parkinson’s disease 37
Characterization of plant bioactive molecules in eukaryotic models of Parkinson’s disease 33
Totale 9.848
Categoria #
all - tutte 31.563
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.563


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020115 0 0 0 0 0 0 0 0 0 0 79 36
2020/20211.181 49 48 104 119 105 68 85 110 92 155 85 161
2021/2022860 69 95 98 90 65 98 62 45 36 42 55 105
2022/20231.213 151 331 128 98 114 139 25 82 63 22 35 25
2023/2024941 28 27 24 102 90 213 139 70 75 17 36 120
2024/20252.712 134 142 337 164 217 179 138 121 322 495 463 0
Totale 9.848